Maria Teixeira-Coelho

Maria Teixeira-Coelho

Auto-generated profile, based on publicly available information

Maria Teixeira-Coelho

Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2010 in Journal of Experimental Medicine
Verified
Journal Article
Open access
RRRichard T. Robinson
Richard T. Robinson
SKShabaana A. Khader
Shabaana A. Khader
CMCynthia A. Martino
Cynthia A. Martino
JFJeffrey J. Fountain
Jeffrey J. Fountain
MTMaria Teixeira-Coelho
Maria Teixeira-Coelho
ACAndrea Cooper
Andrea Cooper
RNA splicing is an increasingly recognized regulator of immunity. Here, we demonstrate that after Mycobacterium tuberculosis infection (mRNA) il12rb1 is spliced by dendritic cells (DCs) to form an alternative (mRNA) il12rb1Δtm that encodes the protein IL-12Rβ1ΔTM. Compared with IL-12Rβ1, IL-12Rβ1ΔTM contains an altered C-terminal sequence and lacks a transmembrane domain. Expression of IL-12Rβ1ΔTM occurs in CD11c+ cells in the lungs during M. tuberculosis infection. Selective reconstitution of il12rb1−/− DCs with (mRNA) il12rb1 and/or (mRNA) il12rb1Δtm demonstrates that IL-12Rβ1ΔTM augments IL-12Rβ1-dependent DC migration and activation of M. tuberculosis-specific T cells. It cannot mediate these activities independently of IL12Rβ1. We hypothesize that M. tuberculosis-exposed DCs express IL-12Rβ1ΔTM to enhance IL-12Rβ1-dependent migration and promote M. tuberculosis–specific T cell activation. IL-12Rβ1ΔTM thus represents a novel positive-regulator of IL12Rβ1-dependent DC function and of the immune response to M. tuberculosis.

25 August 2011 in Genes & Immunity
Verified
Journal Article
Open access
PDF file
ACAgostinho Carvalho
Agostinho Carvalho
CCC Cunha
C Cunha
AAA J Almeida
A J Almeida
Nuno OsórioNuno Osório
Nuno Osório
MSMargarida Saraiva
Margarida Saraiva
Fernando RodriguesFernando Rodrigues
Fernando Rodrigues
Non-Hodgkin lymphoma (NHL) has been associated with immunological defects, chronic inflammatory and autoimmune conditions. Given the link between immune dysfunction and NHL, genetic variants in toll-like receptors (TLRs) have been regarded as potential predictive factors of susceptibility to NHL. Adequate anti-tumoral responses are known to depend on TLR9 function, such that the use of its synthetic ligand is being targeted as a therapeutic strategy. We investigated the association between the functional rs5743836 polymorphism in the TLR9 promoter and risk for B-cell NHL and its major subtypes in three independent case–control association studies from Portugal (1160 controls, 797 patients), Italy (468 controls, 494 patients) and the US (972 controls, 868 patients). We found that the rs5743836 polymorphism was significantly overtransmitted in both Portuguese (odds ratio (OR), 1.85; P=7.3E−9) and Italian (OR, 1.84; P=6.0E−5) and not in the US cohort of NHL patients. Moreover, the increased transcriptional activity of TLR9 in mononuclear cells from patients harboring rs5743836 further supports a functional effect of this polymorphism on NHL susceptibility in a population-dependent manner.

23 November 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ACAgostinho Carvalho
Agostinho Carvalho
Nuno OsórioNuno Osório
Nuno Osório
MSMargarida Saraiva
Margarida Saraiva
CCCristina Cunha
Cristina Cunha
AAAgostinho J. Almeida
Agostinho J. Almeida
Fernando RodriguesFernando Rodrigues
Fernando Rodrigues
In humans, allelic variants in Toll-like receptors (TLRs) associate with several pathologies. However, the underlying cellular and molecular mechanisms of this association remain largely unknown. Analysis of the human TLR9 promoter revealed that the C allele of the rs5743836 polymorphism generates several regulatory sites, including an IL-6-responding element. Here, we show that, in mononuclear cells carrying the TC genotype of rs5743836, IL-6 up-regulates TLR9 expression, leading to exacerbated cellular responses to CpG, including IL-6 production and B-cell proliferation. Our study uncovers a role for the rs5743836 polymorphism in B-cell biology with implications on TLR9-mediated diseases and on the therapeutic usage of TLR9 agonists/antagonists.

14 December 2010 in International Immunology
Verified
Journal Article
Closed access
MTMaria Teixeira-Coelho
Maria Teixeira-Coelho
ACAndrea Cruz
Andrea Cruz
JCJenny Carmona
Jenny Carmona
CSCarole de Sousa
Carole de Sousa
DRDaniela Ramos-Pereira
Daniela Ramos-Pereira
MSMargarida Saraiva
Margarida Saraiva
CD4(+) T(h)1 cells producing IFN-γ are of extreme importance in controlling infections by Mycobacterium tuberculosis both in mice and in men. In addition to IFN-γ-producing T cells, IL-17-producing T cells (T(h)17) have been observed during mycobacterial infections. Nevertheless, their contribution for the host immune response to mycobacteria as well as the signals triggering M. tuberculosis -specific T(h)17 cell differentiation and maintenance are not fully understood. We show that signaling via Toll-like receptor (TLR) 2 has a major impact on the regulation of p19 (IL-23) expression in response to M. tuberculosis and therefore on the establishment of T(h)17 cell responses to M. tuberculosis infection. Diminished T(h)17 responses in the lung of M. tuberculosis -infected TLR2-deficient animals were not caused by defective cell differentiation in the draining lymph node (LN) but rather by reduced maintenance at the site of infection. Consistent with the decreased numbers of T(h)17 cells in the lungs of infected TLR2-deficient animals, we observed reduced expression of CXCL9, CXCL10 and CXCL11, chemokines involved in recall responses to M. tuberculosis. Our data provides insights into the TLR2 role in infection with M. tuberculosis, with implications in pathophysiology of the disease and vaccine design.

5 April 2010 in Journal of Experimental Medicine
Verified
Journal Article
Open access
RRRichard T. Robinson
Richard T. Robinson
SKShabaana A. Khader
Shabaana A. Khader
CMCynthia A. Martino
Cynthia A. Martino
JFJeffrey J. Fountain
Jeffrey J. Fountain
MTMaria Teixeira-Coelho
Maria Teixeira-Coelho
ACAndrea Cooper
Andrea Cooper